Study to assess drospirenone's (DRSP) potential to inhibit Cytochrome P450 3A4 in healthy postmenopausal women
Please see attached Study Results Summary below.
No Inclusion Criteria Available
No Exclusion Criteria Available
Double-blind, randomized, crossover study to assess drospirenone's (DRSP) potential to inhibit Cytochrome P450 3A4 by evaluating the interaction between DRSP at steady state and single doses of the model substrate midazolam in healthy postmenopausal women